Singulex Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Singulex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013508
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and physicians in identifying the biomarkers of disease. Singulex’s SMC technology offer ultrasensitive lab testing services for facilitating proactive health management. The company also provides immunoassay kits and reagents and immunoassay systems. It offers services such as clinical lab testing, patient lab testing, wellness programs, clinical laboratory consulting and billing and client services. The company’s technology is used for medical practice or clinical diagnostics and scientific research applications. Singulex is headquartered in Alameda, California, the US.

Singulex Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Singulex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Singulex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Singulex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Singulex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Singulex Inc, Medical Devices Deals, 2011 to YTD 2017 9
Singulex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Singulex Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Singulex Raises US$12 Million In Series G Financing 11
Singulex Raises US$15.3 Million In Venture Financing 12
Singulex Secures USD15.34 Million in Series F Round of Fundingq 13
Singulex Secures An Additional US$2.17 Million In Venture Financing 14
Partnerships 15
Singulex Forms Joint Venture with Technology Foundation STW 15
Singulex Enters into Development Agreement with CHDI Foundation 16
Licensing Agreements 17
EMD Millipore Enters into Licensing Agreement with Singulex 17
Equity Offering 18
Singulex Withdrawn IPO For Up To US$86 Million 18
Singulex Inc – Key Competitors 19
Singulex Inc – Key Employees 20
Singulex Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Recent Developments 22
Strategy And Business Planning 22
Dec 20, 2016: Singulex Opens European Office and Advances IVD System Evaluation 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Singulex Inc, Pharmaceuticals & Healthcare, Key Facts 2
Singulex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Singulex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Singulex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Singulex Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Singulex Inc, Medical Devices Deals, 2011 to YTD 2017 9
Singulex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Singulex Raises US$12 Million In Series G Financing 11
Singulex Raises US$15.3 Million In Venture Financing 12
Singulex Secures USD15.34 Million in Series F Round of Fundingq 13
Singulex Secures An Additional US$2.17 Million In Venture Financing 14
Singulex Forms Joint Venture with Technology Foundation STW 15
Singulex Enters into Development Agreement with CHDI Foundation 16
EMD Millipore Enters into Licensing Agreement with Singulex 17
Singulex Withdrawn IPO For Up To US$86 Million 18
Singulex Inc, Key Competitors 19
Singulex Inc, Key Employees 20
Singulex Inc, Joint Venture 21

★海外企業調査レポート[Singulex Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Barton Malow Company:企業の戦略・SWOT・財務情報
    Barton Malow Company - Strategy, SWOT and Corporate Finance Report Summary Barton Malow Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Xylem Inc (XYL):電力:M&Aディール及び事業提携情報
    Summary Xylem Inc (Xylem) is a water technology company. It designs, manufactures, and services engineered solutions ranging across a wide variety of applications. The company’s offerings address customer needs across the water cycle, from the delivery, measurement and use of drinking water to the c …
  • RCR Tomlinson Ltd (RCR):企業の財務・戦略的SWOT分析
    RCR Tomlinson Ltd (RCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Stiefel Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary Stiefel Laboratories Inc (Stiefel Laboratories), a subsidiary of GlaxoSmithKline Plc is a healthcare products provider that develops products for sun care, dry skin and clear skin. The company also offers research and development, manufacture, marketing and distribution of prescription medic …
  • Mitsubishi Ufj Financial Group Inc:企業の戦略・SWOT・財務分析
    Mitsubishi Ufj Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Ufj Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • VistaGen Therapeutics Inc (VTGN):医療機器:M&Aディール及び事業提携情報
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • M3 Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary M3 Biotechnology Inc (M3 Biotech) is a clinical stage biotech company that focuses on regenerative medicine. The company is developing clinical programs for the treatment of Alzheimer, MS, Parkinson and Alzheimerdisease (oral) among others. It utilizes discovery platform and develops small m …
  • Genfit SA (GNFT):企業の財務・戦略的SWOT分析
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, NASH, TGFTX1 and Nitazoxanide (NTZ). Its TGFTX1 is a research p …
  • Vivergo Fuels Limited:企業の戦略的SWOT分析
    Vivergo Fuels Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Morgan Stanley Smith Barney LLC:企業の戦略的SWOT分析
    Morgan Stanley Smith Barney LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Afianzadora Latinoamericana Cia de Seguros S.A.:企業の戦略・SWOT・財務情報
    Afianzadora Latinoamericana Cia de Seguros S.A. - Strategy, SWOT and Corporate Finance Report Summary Afianzadora Latinoamericana Cia de Seguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Cryo-Cell International Inc (CCEL):企業の財務・戦略的SWOT分析
    Summary Cryo-Cell International Inc (Cryo-Cell) operates as a cord blood bank service provider. The company offers biotechnology services, collection and preservation of umbilical cord blood stem cells for family use. It provides services such as cord blood banking, cord tissue banking, cord blood a …
  • IRWIN Industrial Tool Co:企業の戦略的SWOT分析
    IRWIN Industrial Tool Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Willis Towers Watson Public Ltd Co:戦略・SWOT・企業財務分析
    Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report Summary Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Even Construtora E Incorporadora Sa
    Even Construtora E Incorporadora Sa - Strategy, SWOT and Corporate Finance Report Summary Even Construtora E Incorporadora Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Alteogen Inc (196170):製薬・医療:M&Aディール及び事業提携情報
    Summary Alteogen Inc (Alteogen) is a biotech company that develops proprietary antibody-drug conjugate and antibody biosimilars. The company’s pipeline products include ALT-P1, ALT-Q2, ALT-P7, ALT-Q5, ALT-L9 and ALT-L2. Its products are used for long-acting human growth hormone, long-acting factor V …
  • AT&T Inc:企業のM&A・事業提携・投資動向
    AT&T Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AT&T Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Edgewell Personal Care LLC (EPC):企業の財務・戦略的SWOT分析
    Edgewell Personal Care LLC (EPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • North Eastern Electric Power Corporation Ltd:企業の戦略的SWOT分析
    North Eastern Electric Power Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Pearl Polymers Ltd.:企業の戦略・SWOT・財務情報
    Pearl Polymers Ltd. - Strategy, SWOT and Corporate Finance Report Summary Pearl Polymers Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆